Technical Trend Overview and Price Movement
Sanofi Consumer Healthcare India Ltd’s current price stands at ₹4,504.10, slightly down from the previous close of ₹4,517.95, reflecting a day change of -0.31%. The stock’s 52-week range spans from ₹3,950.50 to ₹5,394.00, indicating a considerable volatility band over the past year. Despite this, the stock has underperformed relative to the broader market, with a one-week return of -0.71% compared to the Sensex’s modest decline of -0.12%. Over the one-month horizon, the stock has declined by 1.41%, while the Sensex has gained 1.25%, highlighting a divergence in momentum.
Year-to-date, Sanofi Consumer Healthcare has marginally declined by 0.49%, whereas the Sensex has fallen more sharply by 7.84%. However, the stock’s one-year return of -13.24% significantly trails the Sensex’s -1.65%, underscoring the stock’s relative weakness within the Pharmaceuticals & Biotechnology sector.
MACD and Momentum Indicators Signal Mild Bearishness
The Moving Average Convergence Divergence (MACD) indicator on the weekly chart has shifted to a mildly bearish signal, suggesting that the stock’s short-term momentum is weakening. This contrasts with the monthly MACD, which currently does not provide a definitive signal, indicating that longer-term momentum remains uncertain. The weekly MACD’s bearish crossover implies that selling pressure may be increasing, potentially signalling further downside risk in the near term.
Complementing this, the KST (Know Sure Thing) indicator on the weekly timeframe also reflects a mildly bearish stance, reinforcing the notion of a weakening momentum. The Dow Theory analysis aligns with these findings, showing mildly bearish signals on both weekly and monthly charts, which suggests that the stock is in a tentative downtrend phase.
Bollinger Bands and Moving Averages Paint a Mixed Picture
Bollinger Bands on both weekly and monthly charts are currently bearish, indicating that the stock price is trending towards the lower band, which often signals increased volatility and potential downside pressure. This bearish positioning of the Bollinger Bands suggests that the stock may be experiencing heightened selling activity or a lack of buying interest at current levels.
Conversely, the daily moving averages present a mildly bullish signal, implying that short-term price action is somewhat supportive. This divergence between daily moving averages and weekly/monthly indicators highlights a complex technical environment where short-term gains may be offset by broader bearish trends.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
RSI and On-Balance Volume Indicate Neutral Momentum
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in a neutral zone. This suggests that the stock is neither overbought nor oversold, leaving room for either a rebound or further decline depending on market catalysts. Similarly, the On-Balance Volume (OBV) indicator does not exhibit a discernible trend on weekly or monthly timeframes, indicating that volume flows have not decisively favoured buyers or sellers recently.
Market Capitalisation and Mojo Grade Update
Sanofi Consumer Healthcare India Ltd is classified as a small-cap stock, with a MarketsMOJO Mojo Score of 48.0. The company’s Mojo Grade has recently been downgraded from Hold to Sell as of 10 August 2026, reflecting a deteriorating technical and fundamental outlook. This downgrade signals caution for investors, as the stock’s momentum and quality metrics have weakened relative to its peers in the Pharmaceuticals & Biotechnology sector.
Comparative Performance and Sector Context
When compared to the broader Sensex index, Sanofi Consumer Healthcare’s returns have lagged significantly over the past year, with a -13.24% return versus the Sensex’s -1.65%. Over longer horizons, the stock’s performance data is not available for three, five, and ten-year periods, but the Sensex’s robust gains of 19.57%, 43.97%, and 182.78% respectively highlight the stock’s underperformance within the market context.
This underperformance is notable given the Pharmaceuticals & Biotechnology sector’s generally defensive characteristics, which often attract investors during volatile market phases. The stock’s current technical signals suggest that it is struggling to maintain momentum amid sectoral and macroeconomic headwinds.
Sanofi Consumer Healthcare India Ltd or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
Sanofi Consumer Healthcare India Ltd’s recent technical parameter changes indicate a cautious outlook. The mildly bearish weekly MACD and Bollinger Bands, combined with a downgrade in Mojo Grade to Sell, suggest that the stock may face continued pressure in the near term. However, the mildly bullish daily moving averages and neutral RSI imply that short-term rebounds cannot be ruled out.
Investors should weigh these mixed signals carefully, considering the stock’s relative underperformance against the Sensex and the Pharmaceuticals & Biotechnology sector. The absence of strong volume trends and neutral momentum indicators further complicate the outlook, underscoring the need for close monitoring of price action and sector developments.
Given the current technical landscape, a prudent approach would be to await clearer confirmation of trend direction before increasing exposure. Those holding the stock may consider risk management strategies, while prospective investors might explore alternative small-cap opportunities within the sector that demonstrate stronger momentum and fundamental support.
Summary of Key Technical Indicators:
- MACD Weekly: Mildly Bearish
- MACD Monthly: No Signal
- RSI Weekly & Monthly: No Signal
- Bollinger Bands Weekly & Monthly: Bearish
- Moving Averages Daily: Mildly Bullish
- KST Weekly: Mildly Bearish
- Dow Theory Weekly & Monthly: Mildly Bearish
- OBV Weekly & Monthly: No Trend
In conclusion, Sanofi Consumer Healthcare India Ltd’s technical profile reflects a transition towards a mildly bearish momentum phase, tempered by some short-term bullish signals. Investors should remain vigilant and consider the broader market context and sector dynamics when making investment decisions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
